Ask The Recruiter

Corcept Therapeutics Incorporated

Adding Roles, last update 19 hours ago

Pharma biotech · Headquarters United States

Everything we hold on Corcept Therapeutics Incorporated, newest first. Every line links to the filing or report it came from.

6 updates tracked
1 leadership change
31 Dec 2022 tracked since
Houston, United States where
  1. 2026-08-19
    Adding Roles Growing and expanding

    Corcept Therapeutics Incorporated opened 11 more roles in Houston (job board: 68 to 79)

    A board that grows week on week is the earliest public evidence of hiring intent an employer produces: it moves before any announcement and before any filing. Treat the direction as the reliable part and the exact count as approximate, since roles are reposted, split across locations and withdrawn without notice.

    Houston, United States · 11 roles · News Report · Greenhouse job board · No archive snapshot yet. We re-check weekly; next check by Aug 26.

  2. 2026-05-28
    Pay Change Leadership moves

    Corcept Therapeutics Incorporated 8-K filing (Item 5.02): officer or director change

    Corcept Therapeutics amended its incentive plan to allocate more shares, signaling a compensation shift for its workforce in Redwood City.

    United States · Official Filing · SEC EDGAR

  3. 2025-12-31
    Pay Change Pay and benefits

    Corcept Therapeutics Incorporated: $15,303,551 total compensation for the principal executive officer, fiscal year ended 2025-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

  4. 2024-12-31
    Pay Change Pay and benefits

    Corcept Therapeutics Incorporated: $9,890,081 total compensation for the principal executive officer, fiscal year ended 2024-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

  5. 2023-12-31
    Pay Change Pay and benefits

    Corcept Therapeutics Incorporated: $9,337,734 total compensation for the principal executive officer, fiscal year ended 2023-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

  6. 2022-12-31
    Pay Change Pay and benefits

    Corcept Therapeutics Incorporated: $7,352,757 total compensation for the principal executive officer, fiscal year ended 2022-12-31

    Top-of-house pay is the anchor the rest of an employer's pay structure is set against, and it is the one compensation figure every US-listed company must publish on the same basis. Read it as a comparable, not as a salary band: it is a single officer's total, including equity awards valued under SEC rules, and it says nothing directly about what a given role pays.

    United States · Official Filing · SEC EDGAR (pay-versus-performance)

Cite this pageCorcept Therapeutics Incorporated. Talent Intelligence Tracker, AskTheRecruiter.com. Accessed Aug 19, 2026. https://asktherecruiter.com/blog/talent-intelligence-tracker/company/corcept-therapeutics-incorporated/ Licensed CC BY 4.0; every record links to the document behind it.

The read-through on each line is our interpretation. The headline and figures come from the linked source. Data licensed CC BY 4.0. Back to the tracker